Study: Antibody combination shows safety and anti-tumor activity in advanced cancer patients

In an early phase clinical trial, a combination of antibody-based medications targeting the immune system generated promising safety data and anti-tumor activity in individuals with various types of advanced cancer.

Transforming pharmaceutical R&D: the impact of digital technologies on drug discovery and development – Pharmaceutical Technology

Image credit: Gorodenkoff via Shutterstock. The Pharmaceutical Automation and Digitalisation Congress (AUTOMA+) 2024 is a strategic platform for discussion and collaboration among decision makers, researchers

October 30, 2024

The potential benefits of ribavirin and pleconaril treatment on type 1 diabetes

Researchers investigate whether ribavirin and pleconaril could stimulate endogenous insulin production among individuals with incident type 1 diabetes.

October 9, 2023

Oral Cancer Patients Face Worse Outcomes With Delayed Radiation Therapy

MONTREAL – Most patients in a Canadian cohort had prolonged times to postoperative radiation therapy, and those delays were associated with worse survival outcomes, a

July 11, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.